Nerve pain, known clinically as neuropathic pain, is unlike any other type of pain. It does not come from a bruise, a torn muscle, or an inflamed joint. Instead, it originates from damage or dysfunction within the nervous system itself. People describe it as burning, electric, shooting, stabbing, or tingling. It can wake you from sleep, make clothing unbearable against your skin, and resist the painkillers that work for other types of pain.<\/p>\n
An estimated 7% to 10% of the general population experiences neuropathic pain [1]. It can result from diabetes, shingles, surgery, chemotherapy, spinal conditions, autoimmune disease, or physical injury. Whatever the cause, it tends to be persistent and difficult to manage. Standard anti-inflammatory drugs and opioids are largely ineffective for nerve pain, which is why specific treatments have been developed.<\/p>\n
This guide covers both conventional and regenerative approaches to nerve pain treatment, what the evidence says about each, and how to work with your healthcare team to find the right combination for your situation.<\/p>\n
To understand why nerve pain is different, it helps to know a little about how it develops. Normally, nerves transmit signals from your body to your brain in an orderly fashion. You touch something hot, the nerve fires, and you pull your hand away. The system works efficiently.<\/p>\n
When nerves are damaged, this signaling goes wrong in several ways. Damaged nerve fibers may fire spontaneously without any stimulus. They may amplify normal signals, turning a light touch into searing pain (a phenomenon called allodynia). The central nervous system may become sensitized, meaning the brain and spinal cord start amplifying pain signals even when the peripheral input is mild [2].<\/p>\n
This is why nerve pain responds to different treatments than inflammation-based pain. Effective nerve pain treatments work by calming overactive nerve signaling, blocking specific pain pathways, or helping damaged nerves repair and regenerate.<\/p>\n
Nerve pain takes different forms depending on its cause and location.<\/p>\n
Peripheral neuropathy<\/strong> is the most common type, affecting the nerves in the hands and feet. Diabetic neuropathy accounts for a large proportion of cases, but it can also result from vitamin deficiencies (especially B12), alcohol use, chemotherapy, and autoimmune conditions [3].<\/p>\n Postherpetic neuralgia<\/strong> occurs after a shingles outbreak and can persist for months or years after the rash has healed. The varicella-zoster virus damages sensory nerves, causing burning pain in the affected dermatome.<\/p>\n Trigeminal neuralgia<\/strong> produces sudden, severe, shock-like pain in the face. It is caused by compression or irritation of the trigeminal nerve and is considered one of the most intense pain conditions in medicine.<\/p>\n Radiculopathy<\/strong> results from nerve root compression, typically in the spine. Sciatica is the most well-known example, where compression of the lumbar nerve roots causes pain radiating down the leg.<\/p>\n Complex regional pain syndrome (CRPS)<\/strong> is a chronic condition usually affecting a limb after injury or surgery. It involves persistent, disproportionate pain along with changes in skin color, temperature, and swelling.<\/p>\n Several medication classes have established evidence for treating neuropathic pain. These are typically first-line options.<\/p>\n Gabapentinoids are among the most commonly prescribed medications for nerve pain. They work by binding to calcium channels on nerve cells, reducing the release of excitatory neurotransmitters and calming overactive nerve signaling [4].<\/p>\n Gabapentin<\/strong> (Neurontin) has been shown to reduce pain and improve sleep in patients with postherpetic neuralgia and diabetic neuropathy. A Cochrane review found that gabapentin provided at least 50% pain reduction in about 30% to 40% of patients, compared to 10% to 20% with placebo [4]. Typical doses range from 900 to 3,600 mg per day, divided into three doses.<\/p>\n Pregabalin<\/strong> (Lyrica) has a similar mechanism but more predictable absorption. It is FDA-approved for diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury pain. Effective doses typically range from 150 to 600 mg per day [5].<\/p>\n Common side effects of both include dizziness, drowsiness, and weight gain. Starting at a low dose and increasing gradually helps minimize these effects.<\/p>\n Duloxetine (Cymbalta) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain. It works by increasing levels of serotonin and norepinephrine in the descending pain inhibitory pathways, essentially turning up the brain’s natural pain-suppressing system [6].<\/p>\n A meta-analysis found that duloxetine at 60 to 120 mg daily provided clinically meaningful pain relief in about 40% of patients with diabetic neuropathy, compared to 27% with placebo [6]. Venlafaxine, another SNRI, has also shown effectiveness for neuropathic pain, though it is used off-label for this purpose.<\/p>\n Side effects include nausea, dry mouth, constipation, and fatigue. Duloxetine should not be stopped abruptly due to withdrawal effects.<\/p>\n Older tricyclic antidepressants (TCAs) like amitriptyline and nortriptyline remain effective options for neuropathic pain, particularly when prescribed at doses lower than those used for depression. A systematic review found amitriptyline effective for multiple neuropathic pain conditions [7].<\/p>\n TCAs work by inhibiting reuptake of both serotonin and norepinephrine, plus they block sodium channels, which may provide additional pain-reducing effects. Typical pain doses range from 25 to 75 mg at bedtime. Their sedating properties can be beneficial for patients whose nerve pain disrupts sleep.<\/p>\n However, TCAs carry more side effects than newer medications, including dry mouth, constipation, urinary retention, and cardiac conduction changes. They require caution in elderly patients and those with heart disease.<\/p>\n For localized nerve pain, topical options can provide relief with fewer systemic side effects.<\/p>\n Lidocaine patches (5%)<\/strong> are FDA-approved for postherpetic neuralgia and deliver a local anesthetic directly to the painful area. They are particularly useful when pain is confined to a specific region [8].<\/p>\n Capsaicin cream (0.075%) and high-concentration capsaicin patches (8%)<\/strong> work by depleting substance P from sensory nerve endings. The high-concentration patch, applied by a healthcare provider, can provide pain relief lasting up to 3 months from a single application [8].<\/p>\n Alongside conventional treatments, several regenerative and integrative approaches show promise for nerve pain, some with strong evidence and others still emerging.<\/p>\n Platelet-rich plasma (PRP) therapy has shown intriguing results for certain types of nerve pain. The growth factors in PRP, including nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), may support nerve repair and reduce neuroinflammation [9].<\/p>\n Research is most advanced for PRP in nerve entrapment syndromes. A randomized controlled trial comparing PRP injection to corticosteroid injection for carpal tunnel syndrome found that PRP provided superior long-term outcomes, with patients maintaining improvement at 6 months while the corticosteroid group’s benefits had faded [9].<\/p>\n Early research also suggests potential benefits of PRP for peripheral neuropathy. A pilot study found that perineural PRP injection improved symptoms and nerve conduction studies in patients with diabetic neuropathy [10]. However, larger trials are needed before PRP can be considered a standard treatment for neuropathy.<\/p>\n PRP injections for nerve pain are typically performed under ultrasound guidance to ensure accurate placement near the affected nerve. A series of 2 to 4 injections spaced 2 to 4 weeks apart is common.<\/p>\n Stem cell therapy for nerve damage and neuropathic pain is an active area of research. Mesenchymal stem cells (MSCs) have been shown to secrete neurotrophic factors that support nerve survival and regeneration, modulate inflammation, and potentially remyelinate damaged nerves [11].<\/p>\n Animal studies have demonstrated meaningful nerve regeneration with MSC therapy in models of peripheral nerve injury and diabetic neuropathy. Human clinical trials are underway but still in early phases.<\/p>\n It is important to be cautious about clinics offering stem cell therapy for nerve pain outside of clinical trials. The evidence is not yet sufficient to establish efficacy, optimal cell source, dosing, or delivery method for most neuropathic pain conditions. If you are interested in stem cell therapy, seek out centers participating in registered clinical trials.<\/p>\n Low-level laser therapy, also called photobiomodulation, uses specific wavelengths of light to stimulate cellular energy production and reduce inflammation. The mechanism involves absorption of photons by cytochrome c oxidase in mitochondria, which enhances ATP production and activates various cellular signaling pathways [12].<\/p>\n For nerve pain specifically, a systematic review and meta-analysis found that LLLT produced significant reductions in pain intensity for patients with diabetic peripheral neuropathy, carpal tunnel syndrome, and postherpetic neuralgia [12]. The treatment is non-invasive, has virtually no side effects, and can be used alongside other therapies.<\/p>\n Typical protocols involve 2 to 3 sessions per week for 4 to 8 weeks. Results tend to be cumulative, with the full benefit appearing after the complete treatment course. Home devices are available, though their power output is generally lower than clinical units.<\/p>\n Neurofeedback is a form of biofeedback that trains patients to modify their own brain activity. Sensors placed on the scalp measure brain waves (EEG), and the patient receives real-time feedback, usually through a visual or auditory display, that rewards specific patterns of brain activity associated with reduced pain processing [13].<\/p>\n The rationale is that chronic pain alters brain activity patterns, and neurofeedback can help normalize these patterns. A systematic review found that neurofeedback training showed promising results for chronic pain conditions, including neuropathic pain, with reductions in pain intensity and improvements in quality of life [13].<\/p>\n Neurofeedback typically requires 20 to 40 sessions for full effect, making it a significant time commitment. It is most appropriate for chronic, treatment-resistant nerve pain and works best as part of a multimodal treatment approach rather than a standalone therapy.<\/p>\n Ketamine, an NMDA receptor antagonist, has gained attention as a treatment for severe, treatment-resistant neuropathic pain. NMDA receptors play a central role in central sensitization, the process by which the spinal cord and brain amplify pain signals. By blocking these receptors, ketamine can interrupt the cycle of central sensitization [14].<\/p>\n Intravenous ketamine infusions have shown effectiveness in multiple neuropathic pain conditions, including CRPS, postherpetic neuralgia, and central neuropathic pain. A systematic review found that IV ketamine provided significant short-term pain relief in patients with refractory neuropathic pain [14].<\/p>\n Newer delivery methods include intranasal, oral, and topical ketamine formulations, though IV infusion remains the most studied. Treatment typically involves a series of infusions over several days to weeks, with some patients experiencing lasting relief and others requiring periodic maintenance infusions.<\/p>\n Side effects can include dissociation, dizziness, nausea, and elevated blood pressure during infusion. Ketamine should only be administered by trained providers in a monitored setting. It is typically reserved for patients who have not responded adequately to first-line treatments.<\/p>\n Alongside medical treatments, several lifestyle factors can meaningfully influence nerve pain.<\/p>\n Regular physical activity has been shown to reduce neuropathic pain through multiple mechanisms, including improved blood flow to nerves, release of endogenous opioids, and modulation of neuroinflammation. A systematic review found that exercise interventions improved pain, physical function, and nerve conduction measures in patients with diabetic peripheral neuropathy [15].<\/p>\n Both aerobic exercise and resistance training appear beneficial. Start gently and progress gradually, especially if balance is affected by neuropathy. Swimming and cycling may be easier than walking for people with foot pain.<\/p>\n For diabetic neuropathy, optimizing blood glucose control is the single most important intervention. Tight glycemic control can slow the progression of neuropathy and, in some cases, lead to partial reversal of nerve damage, particularly in early stages [3].<\/p>\n Several nutrients are important for nerve health:<\/p>\n Chronic stress amplifies pain perception through the hypothalamic-pituitary-adrenal axis. Mindfulness-based stress reduction (MBSR) has been shown to reduce pain intensity and improve coping in chronic pain conditions. Practices like meditation, deep breathing, and yoga can be valuable additions to a nerve pain management plan.<\/p>\n Effective nerve pain management usually requires a combination of approaches. A reasonable progression looks like this:<\/p>\n Seek medical evaluation promptly if you experience:<\/p>\n A neurologist can perform nerve conduction studies and electromyography to characterize the type and extent of nerve damage, which helps guide treatment decisions. Pain management specialists can offer interventional procedures and multimodal treatment plans.<\/p>\n Nerve pain is one of the more challenging types of chronic pain to manage, but the treatment options continue to expand. Conventional medications like gabapentinoids, SNRIs, and tricyclic antidepressants remain the foundation of treatment. Regenerative approaches, including PRP, LLLT, and neurofeedback, offer additional tools that work alongside conventional care. Ketamine provides a powerful option for severe, refractory cases.<\/p>\n The key is to address nerve pain from multiple angles: treat the underlying cause, use medications that target neuropathic pain pathways, optimize lifestyle factors that support nerve health, and consider regenerative options that may promote healing rather than just managing symptoms. Working with a knowledgeable healthcare team that understands both conventional and integrative options gives you the best chance of meaningful relief.<\/p>\n [1] van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain<\/em>. 2014;155(4):654-662. doi:10.1016\/j.pain.2013.11.013<\/p>\n [2] Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci<\/em>. 2009;32:1-32. doi:10.1146\/annurev.neuro.051508.135531<\/p>\n [3] Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care<\/em>. 2017;40(1):136-154. doi:10.2337\/dc16-2042<\/p>\n [4] Wiffen PJ, Derry S, Bell RF, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev<\/em>. 2017;6(6):CD007938. doi:10.1002\/14651858.CD007938.pub4<\/p>\n [5] Derry S, Bell RF, Straube S, et al. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev<\/em>. 2019;1(1):CD007076. doi:10.1002\/14651858.CD007076.pub3<\/p>\n [6] Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev<\/em>. 2014;(1):CD007115. doi:10.1002\/14651858.CD007115.pub3<\/p>\n [7] Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev<\/em>. 2015;(7):CD008242. doi:10.1002\/14651858.CD008242.pub3<\/p>\n [8] Derry S, Wiffen PJ, Kalso EA, et al. Topical analgesics for acute and chronic pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev<\/em>. 2017;5(5):CD008609. doi:10.1002\/14651858.CD008609.pub2<\/p>\n [9] Malahias MA, Johnson EO, Babis GC, Nikolaou VS. Single injection of platelet-rich plasma as a novel treatment of carpal tunnel syndrome. Neural Regen Res<\/em>. 2015;10(11):1856-1859. doi:10.4103\/1673-5374.165322<\/p>\n [10] Anjayani S, Wirohadidjojo YW, Adam AM, Suwandi D, Seweng A, Amiruddin MD. Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma. Int J Dermatol<\/em>. 2014;53(1):109-113. doi:10.1111\/ijd.12162<\/p>\n [11] Liau LL, Looi QH, Chia WC, Subramaniam T, Ng MH, Law JX. Treatment of spinal cord injury with mesenchymal stem cells. Cell Biosci<\/em>. 2020;10:36. doi:10.1186\/s13578-020-00396-1<\/p>\n [12] Bjordal JM, Johnson MI, Iversen V, Aimbire F, Lopes-Martins RA. Low-level laser therapy in acute pain: a systematic review of possible mechanisms of action and clinical effects in randomized placebo-controlled trials. Photomed Laser Surg<\/em>. 2006;24(2):158-168. doi:10.1089\/pho.2006.24.158<\/p>\n [13] Roy R, de la Vega R, Jensen MP, Mir\u00f3 J. Neurofeedback for pain management: a systematic review. Front Neurosci<\/em>. 2020;14:671. doi:10.3389\/fnins.2020.00671<\/p>\n [14] Orhurhu V, Orhurhu MS, Bhatia A, Cohen SP. Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg<\/em>. 2019;129(1):241-254. doi:10.1213\/ANE.0000000000004185<\/p>\n [15] Kluding PM, Pasnoor M, Singh R, et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications<\/em>. 2012;26(5):424-429. doi:10.1016\/j.jdiacomp.2012.05.007<\/p>\n","protected":false},"excerpt":{"rendered":" Explore evidence-based nerve pain treatments from conventional medications to regenerative options like PRP, LLLT, neurofeedback, and ketamine therapy.<\/p>\n","protected":false},"author":1,"featured_media":6369,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_regenerated_references":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-5903","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nervous-system"],"_links":{"self":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/comments?post=5903"}],"version-history":[{"count":1,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5903\/revisions"}],"predecessor-version":[{"id":6370,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5903\/revisions\/6370"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media\/6369"}],"wp:attachment":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media?parent=5903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/categories?post=5903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/tags?post=5903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Conventional Pharmaceutical Treatments<\/h2>\n
Gabapentin and Pregabalin<\/h3>\n
Duloxetine and Other SNRIs<\/h3>\n
Tricyclic Antidepressants<\/h3>\n
Topical Treatments<\/h3>\n
Regenerative and Integrative Approaches<\/h2>\n
PRP for Nerve Pain<\/h3>\n
Stem Cell Therapy for Nerve Regeneration<\/h3>\n
Low-Level Laser Therapy (LLLT)<\/h3>\n
Neurofeedback<\/h3>\n
Ketamine Therapy<\/h3>\n
Lifestyle Approaches That Support Nerve Health<\/h2>\n
Exercise<\/h3>\n
Blood Sugar Management<\/h3>\n
Nutrient Support<\/h3>\n
\n
Stress Management<\/h3>\n
Building a Treatment Plan<\/h2>\n
When to See a Specialist<\/h2>\n
\n
The Bottom Line<\/h2>\n
References<\/h2>\n